Repurposing of drugs for triple negative breast cancer: an overview

Breast cancer (BC) is the most frequent cancer among women in the world and it remains a leading cause of cancer death in women globally. Among BCs, triple negative breast cancer (TNBC) is the most aggressive, and for its histochemical and molecular characteristics is also the one whose therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Spini, Andrea, Donnini, Sandra, Pantziarka, Pan, Crispino, Sergio, Ziche, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373643/
https://www.ncbi.nlm.nih.gov/pubmed/32728387
http://dx.doi.org/10.3332/ecancer.2020.1071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373643/
https://www.ncbi.nlm.nih.gov/pubmed/32728387
http://dx.doi.org/10.3332/ecancer.2020.1071

Ejemplares similares